Giulio Rocchi

Targeting the Inflammatory Pathway as a Therapeutic Tool for Major Depression

An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline

Major depressive disorder

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder

Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance

Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds